CureMint Welcomes John Klavon as VP of Sales and Business Development

Share This Post

Key Highlights

  • CureMint names John Klavon as Vice President of Sales and Business Development.
  • Klavon brings over 32 years of dental and B2B sector experience.
  • Led procurement at Frontline Dental, achieving $2.8 million in savings using CureMint’s platform.
  • Expertise in unifying Procurement and A/P workflows to drive efficiency and growth.

Source: Business Wire

Notable Quotes

  • “John recognized that today’s modern dental organizations need more than a procurement solution. They need an integrated Procure-to-Pay solution.” — Tyson Nargassans, CEO at CureMint
  • “I’m excited to join CureMint and look forward to leveraging my experience in the dental industry to contribute to CureMint’s vision and long-term success.” — John Klavon, VP of Sales and Business Development at CureMint

SoHC's Take

CureMint’s appointment of John Klavon marks a pivotal moment for the company, aligning with its mission to continue expanding its foothold in the dental sector. Klavon’s extensive leadership experience and firsthand success with CureMint’s platform at Frontline Dental suggest he is well-positioned to drive both sales and innovation. His deep understanding of dental organizations’ unique challenges, combined with his strategic mindset, will undoubtedly help CureMint further solidify its position as a leader in Procure-to-Pay solutions.

Heading

Key Highlights Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector. Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine ...
/
Key Highlights Nymbl Systems announces strategic partnership with Frontier Growth to accelerate growth and innovation. Frontier Growth brings 25+ years of growth equity expertise to ...
/
Key Highlights Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems. Revolutionizes access with fewer ...
/
Key Highlights Anatomy Financial raises $19M in Series A funding, led by Canapi Ventures. Neil Underwood (Canapi) and Nicole Quinn ...
/
Key Highlights Wendy Barnes to assume role as GoodRx CEO on January 1, 2025. Brings 30+ years of leadership in pharmacy and healthcare benefit industries. Former CEO of RxBenefits and President of Express ...
/
Key Highlights Mike Butler, former Providence president, joins Linus Health's board of directors. Butler brings decades of healthcare leadership and ...
/

More To Explore

Total
0
Share